PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
-1.75%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.81B
AUM Growth
-$55.5M
(-3%)
Cap. Flow
+$877K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
31.67%
Holding
1,104
New
38
Increased
236
Reduced
694
Closed
136
Top Buys
| 1 |
Broadcom
AVGO
|
+$6.48M |
| 2 |
Costco
COST
|
+$4.36M |
| 3 |
PepsiCo
PEP
|
+$4.02M |
| 4 |
Adobe
ADBE
|
+$3.79M |
| 5 |
Cisco
CSCO
|
+$3.39M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$14.1M |
| 2 |
Microsoft
MSFT
|
+$14M |
| 3 |
Amazon
AMZN
|
+$10.6M |
| 4 |
Tesla
TSLA
|
+$6.62M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$4.66M |
Sector Composition
| 1 | Technology | 38.18% |
| 2 | Healthcare | 14.97% |
| 3 | Consumer Discretionary | 11.55% |
| 4 | Communication Services | 9.62% |
| 5 | Energy | 6.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Agios Pharmaceuticals
AGIO
$2.06B
| $572K | 0.03% |
23,116
-7,028
| -23% | -$174K |
|
427
Qorvo
QRVO
$8.18B
| $572K | 0.03% |
5,992
+7
| +0.1% | +$668 |
|
428
AB InBev
BUD
$115B
| $572K | 0.03% |
10,342
-612
| -6% | -$33.8K |
|
429
Moody's
MCO
$91.5B
| $570K | 0.03% |
1,803
-75
| -4% | -$23.7K |
|
430
Arcturus Therapeutics
ARCT
$478M
| $570K | 0.03% |
22,298
-6,310
| -22% | -$161K |
|
431
Lennar Class A
LEN
$35.3B
| $569K | 0.03% |
5,235
-1,364
| -21% | -$148K |
|
432
Axsome Therapeutics
AXSM
$6.33B
| $568K | 0.03% |
8,133
-711
| -8% | -$49.7K |
|
433
Teladoc Health
TDOC
$1.36B
| $568K | 0.03% |
30,535
+1,557
| +5% | +$28.9K |
|
434
iQIYI
IQ
$2.52B
| $567K | 0.03% |
119,573
+6,987
| +6% | +$33.1K |
|
435
Arthur J. Gallagher & Co
AJG
$75.7B
| $562K | 0.03% |
2,467
-98
| -4% | -$22.3K |
|
436
Truist Financial
TFC
$58.4B
| $561K | 0.03% |
19,592
-703
| -3% | -$20.1K |
|
437
Aptiv
APTV
$17.8B
| $560K | 0.03% |
5,676
-1,131
| -17% | -$112K |
|
438
IQVIA
IQV
$32B
| $556K | 0.03% |
2,825
-81
| -3% | -$15.9K |
|
439
Royalty Pharma
RPRX
$15.8B
| $554K | 0.03% |
20,417
+2,071
| +11% | +$56.2K |
|
440
Huazhu Hotels Group
HTHT
$11.3B
| $553K | 0.03% |
14,035
-1,990
| -12% | -$78.5K |
|
441
Ambev
ABEV
$35.1B
| $551K | 0.03% |
213,515
-20,421
| -9% | -$52.7K |
|
442
Fastly
FSLY
$1.12B
| $548K | 0.03% |
28,599
-7,122
| -20% | -$137K |
|
443
Coherus Oncology, Inc. Common Stock
CHRS
$156M
| $546K | 0.03% |
+145,989
| New | +$546K |
|
444
Travere Therapeutics
TVTX
$2.48B
| $545K | 0.03% |
60,983
-28,947
| -32% | -$259K |
|
445
Rio Tinto
RIO
$101B
| $543K | 0.03% |
8,527
-505
| -6% | -$32.1K |
|
446
Equinor
EQNR
$61.9B
| $541K | 0.03% |
16,511
-976
| -6% | -$32K |
|
|
MORF
447
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $540K | 0.03% |
23,568
-124
| -0.5% | -$2.84K |
|
448
Replimune Group
REPL
$452M
| $540K | 0.03% |
31,557
+5,045
| +19% | +$86.3K |
|
449
Digital Realty Trust
DLR
$59.3B
| $539K | 0.03% |
4,457
+53
| +1% | +$6.41K |
|
450
Axcelis
ACLS
$2.6B
| $539K | 0.03% |
3,305
+1,375
| +71% | +$224K |
|